Feb 7 |
Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)
|
Feb 7 |
Terns Pharmaceuticals appoints Burroughs as CEO
|
Feb 7 |
Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer
|
Feb 2 |
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
|
Jan 4 |
Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare Conference
|
Nov 29 |
Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit
|
Nov 27 |
Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive Officer
|
Nov 14 |
Terns Pharmaceuticals GAAP EPS of -$0.42 misses by $0.12
|
Nov 14 |
Terns Pharmaceuticals Inc (TERN) Reports Q3 2023 Financials and Corporate Progress
|
Nov 14 |
Recap: Terns Pharma Q3 Earnings
|